Treatment of T4 esophageal cancer. Definitive chemo-radiotherapy vs chemo-radiotherapy followed by surgery

Annals of Thoracic and Cardiovascular Surgery

Volumn 17, Issue 3, 2011, Pages 221-228

  Makino, Tomoki ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Definitive chemo radiotherapy; Esophageal cancer; Esophagectomy; Neo adjuvant chemo radiotherapy; T4

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; MORTALITY; PATHOLOGY; PATIENT SELECTION; REVIEW; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 79959690768     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: 10.5761/atcs.ra.11.01676     Document Type: Review

References (45)

1. Gamliel Z, Krasna MJ. Multimodality treatment of esophageal cancer. Surg Clin North Am 2005; 85: 621-30.
2. Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, et al. Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg 2006; 30: 1441-9.
3. Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 2003; 133: 24-31.
4. Ichiyoshi Y, Kawahara H, Taga S, Yoshino I, Ohsaki T, et al. Indications and operative techniques for combined aortoesophageal resection. Jpn J Thorac Cardiovasc Surg 1999; 47: 318-24.
5. Shenfine J, McNamee P, Steen N, Bond J, Griffin SM. A pragmatic randomised controlled trial of the costeffectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess 2005; 9: iii, 1-121.
6. Fujita H, Kakegawa T, Kawahara H, Yamana H, Shima I, et al. Questionable resection for carcinoma of the esophagus involving the trachea, bronchus and/or aorta--a comparative and multivariate analysis. Kurume Med J 1992; 39: 183-9.
7. Ancona E, Ruol A, Castoro C, Chiarion-Sileni V, Merigliano S, et al. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up. Ann Surg 1997; 226: 714-23.
8. John MJ, Flam MS, Mowry PA, Podolsky WJ, Xavier AM, et al. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989; 63: 2397-403.
9. Tsujinaka T, Shiozaki H, Yamamoto M, Inoue M, Yano M, et al. Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma. Am J Surg 1999; 177: 503-6.
10. Seto Y, Chin K, Gomi K, Kozuka T, Fukuda T, et al. Treatment of thoracic esophageal carcinoma invading adjacent structures. Cancer Sci 2007; 98: 937-42.
11. Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Matono S, et al. Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg 2005; 29: 25-30.
12. de Manzoni G, Pedrazzani C, Pasini F, Bernini M, Minicozzi AM, et al. Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. J Surg Oncol 2007; 95: 261-6.
13. Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, et al. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer. J Surg Oncol 2009; 99: 302-6.
14. Noguchi T, Moriyama H, Wada S, Takeno S, Wakisaka M, et al. Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esophagus 2003; 16: 94-8.
15. Ikeda K, Ishida K, Sato N, Koeda K, Aoki K, et al. Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus 2001; 14: 197-201.
16. Yano M, Tsujinaka T, Shiozaki H, Inoue M, Doki Y, et al. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J Surg Oncol 1999; 70: 25-32.
17. Font A, Arellano A, Fernández-Llamazares J, Casas D, Boix J, et al. Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer. Clin Transl Oncol 2007; 9: 177-82.
18. Crosby TD, Brewster AE, Borley A, Perschky L, Kehagioglou P, et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer 2004; 90: 70-5.
19. Kaneko K, Ito H, Konishi K, Kurahashi T, Ito T, et al. Definitive chemoradiotherapy for patients with malignant str icture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br J Cancer 2003; 88: 18-24.
20. Itoh Y, Fuwa N, Matsumoto A, Asano A, Morita K. Outcomes of radiotherapy for inoperable locally advanced (T4) esophageal cancer-retrospective analysis. Radiat Med 2001; 19: 231-5.
21. Ohtsu A, Boku N, Muro K, Chin K, Muto M, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
22. Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, et al. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 2002; 53: 134-9.
23. The National Cancer Center Institute Common Toxicity Criteria version 2.0.
24. Lerut TE, de Leyn P, Coosemans W, Van Raemdonck D, Cuypers P, et al. Advanced esophageal carcinoma. World J Surg 1994; 18: 379-87.
25. Junginger T, Dutkowski P. Selective approach to the treatment of oesophageal cancer. Br J Surg 1996; 83: 1473-7.
26. Hölscher AH, Bollschweiler E, Bumm R, Bartels H, Höfler H, et al. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995; 118: 845-55.
27. Fok M, Law SY, Wong J. Operable esophageal carcinoma: current results from Hong Kong. World J Surg 1994; 18: 355-60.
28. Matsubara T, Ueda M, Kokudo N, Takahashi T, Muto T, et al. Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg 2001; 25: 279-84.
29. Higuchi I, Yasuda T, Yano M, Doki Y, Miyata H, et al. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival af ter subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2008; 136: 205-12, 212. e1-3.
30. Vallböhmer D, Hölscher AH, Dietlein M, Bollschweiler E, Baldus SE, et al. [18F]-Fluorodeoxyglucosepositron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg 2009; 250: 888-94.
31. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
32. al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997; 15: 277-84.
33. Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42: 269-76.
34. Ishida K, Iizuka T, Ando N, Ide H. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial. Jpn J Clin Oncol 1996; 26: 310-5.
35. Roussel A CS, Jacob JH. Radiation therapy in esophagal carcinoma with broncho-tracheal involvement (BTI): The center Francois Baclesse (CFB) experience. Proc Am Soc Clin Oncol 1995; 14: 190a. (Abstract).
36. Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol 2004; 34: 615-9.
37. Yamada S, Takai Y, Ogawa Y, Kakuto Y, Sakamoto K. Radiotherapy for malignant fistula to other tract. Cancer 1989; 64: 1026-8.
38. Malik SM, Krasnow SH, Wadleigh RG. Closure of tracheoesophageal fistulas with primary chemotherapy in patients with esophageal cancer. Cancer 1994; 73: 1321-3.
39. Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD, et al. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol 2008; 26: 4551-6.
40. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combinedmodality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
41. Tachibana M, Dhar DK, Kinugasa S, Yoshimura H, Shibakita M, et al. Surgical treatment for locally advanced (T4) squamous cell carcinoma of the thoracic esophagus. Dysphagia 2002; 17: 255-61.
42. Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, et al. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy followed by esophagectomy for T4 esophageal cancers. J Surg Oncol 2005; 90: 209-19.
43. Van Raemdonck D, Van Cutsem E, Menten J, Ectors N, Coosemans W, et al. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg 1997: 11: 828-37.
44. Yano M, Shiozaki H, Tsujinaka T, Inoue M, Doki Y, et al. Squamous cell carcinoma of the esophagus infiltrating the respiratory tract is less sensitive to preoperative concurrent radiation and chemotherapy. J Am Coll Surg 2000; 191: 626-34.
45. Bedenne L, Michel P, Bouché O, Milan C, Mariette C, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-8.